ChemBioChem · 2002 · 74 citations · 15 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructural BiologyCrystal ChemistryLigand BindingProtein StructureProtein-ligand DockingStructural Basis Of RecognitionStructural RefinementBinding Mode AnalysisBinding Mode PredictionMolecular Property-based DesignStructure-based Binding MechanismsStructure-based Binding PredictionStructure-based Lead DiscoveryStructure-based Ligand Design
Drug lead compound identification increasingly uses high-throughput screening in conjunction with computational methods. Hits found in this way are generally of low affinity (typically about 10−5 M) and require further development. Such low affinity can result in significant changes in binding mode upon change of experimental conditions: at pH 7, the Factor Xa inhibitor 1 (see picture) binds in the specificity pocket of trypsin through its pyridinyl group (yellow); at pH 8, the same pocket is occupied by the chloronaphthyl moiety (magenta), with a significant reorganization of the ligand binding site (circled).
15
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
T. Alwyn Jones, Jin-yu Zou, Sandra W. Cowan et al. · Acta Crystallographica Section A Foundations of Crystallography · 1991 · 12.7K citations
X-ray Structure of Active Site-inhibited Clotting Factor Xa
Hans Brandstetter, Anja Kühne, Wolfram Bode et al. · Journal of Biological Chemistry · 1996 · 278 citations · Full text